Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse
A retrospective review of DLBCL patients treated at MSKCC w/HD MTX ppx failed to show a persistent benefit in decreasing CNS relapse rates. This study adds to the recent data questioning the utility of CNS prophylaxis.